Early research (Phase 1)Ended earlyNCT04800822What this trial is testingPF-07284892 in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Pfizer 53
Testing effectiveness (Phase 2)Looking for participantsNCT07174583What this trial is testingIDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerWho this might be right forSmall-cell Lung CancerNeuroendocrine CarcinomasSolid Tumor Show to Express DLL3 IDEAYA Biosciences 262
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272What this trial is testingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more 23andMe, Inc. 141
Early research (Phase 1)Study completedNCT04344795What this trial is testingPhase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsWho this might be right forSolid TumorColorectal CancerNon Small Cell Lung Cancer+6 more Tempest Therapeutics 89
Early research (Phase 1)WithdrawnNCT05039931What this trial is testingGNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd.
Early research (Phase 1)Ended earlyNCT04209465What this trial is testingBDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.Who this might be right forSolid Tumor Black Diamond Therapeutics, Inc. 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667What this trial is testingQUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsWho this might be right forNon-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more ImmunityBio, Inc. 40
Early research (Phase 1)Looking for participantsNCT07056556What this trial is testingBL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid TumorsWho this might be right forNon-small Cell Lung CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 31
Early research (Phase 1)Active Not RecruitingNCT05557045What this trial is testingJZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Who this might be right forAdvanced CancerMetastatic CancerSolid Tumor+4 more Jazz Pharmaceuticals 98
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Early research (Phase 1)Study completedNCT00046111What this trial is testingA Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid TumorsWho this might be right forLung Cancer, Small CellSolid Tumor Cancer GlaxoSmithKline 1
Testing effectiveness (Phase 2)Ended earlyNCT05363605What this trial is testing[225Ac]-FPI-1966 in Participants With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more Fusion Pharmaceuticals Inc. 6
Early research (Phase 1)Ended earlyNCT03343613What this trial is testingLY3381916 Alone or in Combination With LY3300054 in Participants With Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more Eli Lilly and Company 60
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Early research (Phase 1)Ended earlyNCT05769959What this trial is testingStudy of RO7515629 in Participants With HLA-G Positive Solid TumorsWho this might be right forRenal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Early research (Phase 1)Looking for participantsNCT06171750What this trial is testingPhase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more Ankyra Therapeutics, Inc 97
Early research (Phase 1)Not Yet RecruitingNCT07423117What this trial is testingITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyWho this might be right forMetastatic Castration-resistant Prostate CancerNon-small Cell Lung CancerTriple Negative Breast Cancer+1 more IntoCell, Inc 102
Testing effectiveness (Phase 2)Looking for participantsNCT06162221What this trial is testingStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCWho this might be right forNon-Small Cell Lung Cancer, NSCLCKRAS, NRAS, HRAS-mutated NSCLCKRAS G12C-mutated Solid Tumors, Lung Cancer+2 more Revolution Medicines, Inc. 616
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5